Prosecution Insights
Last updated: April 19, 2026

Squire Pb (T. Lorenz)

19 pending office actions • 12 clients

Portfolio Summary

19
Total Pending OAs
4
Final Rejections
15
Non-Final OAs

Client Portfolio (12 clients)

Client (Assignee)Pending OAs
Engene, Inc. 3
The University of British Columbia 2
Phenomic AI 2
Esperovax Inc. 2
Inmed Pharmaceuticals Inc. 2
Adicet Therapeutics, Inc. 2
Aspect Biosystems Ltd. 1
Aspect Biosystems Ltd. 1
The Cleveland Clinic Foundation 1
BAYMEDICA, INC. 1
The University of British Columbia 1
Eppendorf SE 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18686755 MICROFLUIDIC-BASED FIBER FORMATION METHODS AND SYSTEMS Aspect Biosystems Ltd. SWANSON, ANDREW L 1745 Non-Final OA Feb 26, 2024
18417258 NOVEL AMINE FUNCTIONALIZED POLYMERS AND METHODS OF PREPARATION The University of British Columbia BOYLE, ROBERT C 1764 Non-Final OA Jan 19, 2024
18563872 SELECTIVELY PERMEABLE ANNULUS FIBERS AND METHODS OF USING SAME Aspect Biosystems Ltd. HAGOPIAN, CASEY SHEA 1617 Non-Final OA Nov 22, 2023
18277944 COMBINATION GENE THERAPY FOR TREATMENT OF METASTATIC CANCER Engene, Inc. POLIAKOVA-GEORGAN, EKATERINA 1637 Non-Final OA Aug 18, 2023
18275797 MICRO RNA LIVER CANCER MARKERS AND USES THEREOF The Cleveland Clinic Foundation YU, TIAN NMN 1681 Non-Final OA Aug 03, 2023
18273261 ACYL ACTIVATING ENZYMES FOR PREPARATION OF CANNABINOIDS BAYMEDICA, INC. SAIDHA, TEKCHAND 1652 Non-Final OA Jul 19, 2023
18269539 ANTI-ACTIVIN ANTIBODIES AND METHODS OF USING THE SAME Phenomic AI ALSOMAIRY, SARAH ABDOALATIF 1646 Non-Final OA Jun 23, 2023
18268464 METHODS FOR HYDROAMINOALKYLATION OF OLEFINS AND GROUP 4 METAL COMPLEXES USEFUL IN SUCH METHODS The University of British Columbia BOYLE, ROBERT C 1764 Non-Final OA Jun 20, 2023
18212115 Dissolved Protein Arthritis Markers The University of British Columbia HOWELL, THEODORE R 1628 Non-Final OA Jun 20, 2023
18038673 YEAST-BASED EXPRESSION OF THERAPEUTIC PROTEINS IN VIVO Esperovax Inc. CHEN, STACY BROWN 1672 Non-Final OA May 24, 2023
18033187 COMPOSITIONS AND METHODS FOR TREATING NEURONAL DISORDERS WITH CANNABINOIDS Inmed Pharmaceuticals Inc. MOU, LIYUAN 1628 Non-Final OA Apr 21, 2023
18121557 INTESTINAL EXPRESSION OF PROGRAMMED DEATH LIGAND 1 Engene, Inc. OUSPENSKI, ILIA I 1644 Non-Final OA Mar 14, 2023
17918882 SYSTEM AND METHOD FOR PROFILING ANTIBODIES WITH HIGH-CONTENT SCREENING (HCS) Phenomic AI PHAM, TUAN A 2163 Non-Final OA Oct 13, 2022
17794577 LOCALIZED EXPRESSION OF THERAPEUTIC NUCLEIC ACIDS IN LUNG EPITHELIAL CELLS Engene, Inc. MILLER, DALE R 1693 Non-Final OA Jul 21, 2022
17782129 METHODS FOR EXPANDING GAMMA DELTA T-CELL POPULATIONS WITH MULTIVALENT AGENTS AND COMPOSITIONS THEREOF Adicet Therapeutics, Inc. HECK, BRYAN WILLIAM 1643 Non-Final OA Jun 02, 2022
17612179 Yeast-Based Oral Vaccination Esperovax Inc. LI, BAO Q 1671 Final Rejection Nov 17, 2021
17606003 COMPOSITIONS AND METHODS FOR USE OF CANNABINOIDS FOR NEUROPROTECTION Inmed Pharmaceuticals Inc. REILLY, SOPHIA JANE 1627 Final Rejection Oct 22, 2021
17298903 METHODS FOR SELECTIVE IN VIVO EXPANSION OF GAMMA DELTA T-CELL POPULATIONS AND COMPOSITIONS THEREOF Adicet Therapeutics, Inc. SKELDING, ZACHARY S 1644 Final Rejection Jun 01, 2021
17278007 Method for controlling a thermal cycler, and thermal cycler Eppendorf SE GORDON, BRIAN R 1798 Final Rejection Mar 19, 2021

Managing Squire Pb (T. Lorenz)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month